Medicare Enrolled
Dr. Mihir Barvalia, MD
Cardiovascular Disease · El Cajon, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Barvalia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barvalia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barvalia
Dr. Mihir Barvalia is a cardiovascular disease specialist in El Cajon, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Barvalia performed 2,361 Medicare services across 1,557 unique beneficiaries.
Between the years covered by Open Payments, Dr. Barvalia received a total of $123,702 from 60 pharmaceutical and/or device companies across 760 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barvalia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 43% volume in CA
$123,702 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,361
Medicare services
Top 43% in CA for cardiovascular disease
1,557
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~182 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
526 | $94 | $167 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
444 | $99 | $177 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
297 | $11 | $28 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
168 | $136 | $340 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
133 | $65 | $188 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
95 | $165 | $350 |
| Heart muscle strain imaging | 93 | $32 | $68 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
65 | $110 | $265 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
56 | $105 | $350 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
55 | $153 | $340 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
50 | $10 | $91 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
44 | $7 | $19 |
| Cardiac catheterization | 42 | $178 | $602 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
40 | $209 | $434 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
35 | $184 | $373 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
27 | $13 | $28 |
| CT scan of heart blood vessels and grafts with contrast A CT scan that uses contrast dye to create detailed images of the heart's blood vessels and any surgical grafts. |
24 | $90 | $195 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
24 | $65 | $145 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
23 | $2 | $35 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
21 | $14 | $85 |
| 3D radiographic procedure A radiographic imaging technique that creates three-dimensional representations of internal structures. |
18 | $8 | $38 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
18 | $84 | $183 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
14 | $444 | $1,146 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
14 | $20 | $137 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
13 | $72 | $180 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
11 | $20 | $114 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
11 | $748 | $1,624 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.3% high complexity
14.4% medium
78.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$123,702
Total received (2018-2024)
Avg $17,672/year across 7 years
Top 6% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
760
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90,596 (73.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,956 (20.2%)
Scientific / Research
Research funding and grants
$8,150 (6.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$68,301
2023
$14,852
2022
$20,961
2021
$5,748
2020
$577
2019
$3,863
2018
$9,401
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$55,351
Kiniksa Pharmaceuticals International, plc
$6,762
Abbott Laboratories
$1,454
Edwards Lifesciences Corporation
$1,092
Chiesi USA, Inc.
$741
Medtronic, Inc.
$364
SCPHARMACEUTICALS INC.
$328
Reflow Medical Inc
$214
ShockWave Medical, Inc
$209
ABIOMED
$198
Novartis Pharmaceuticals Corporation
$170
AstraZeneca Pharmaceuticals LP
$152
Actelion Pharmaceuticals US, Inc.
$131
iRhythm Technologies, Inc.
$121
Alnylam Pharmaceuticals Inc.
$103
ASAHI INTECC USA, INC.
$91
CVRx, Inc.
$88
HEARTFLOW, INC.
$80
Merck Sharp & Dohme LLC
$78
Amgen Inc.
$78
E.R. Squibb & Sons, L.L.C.
$72
Janssen Pharmaceuticals, Inc
$67
Inari Medical, Inc.
$61
PFIZER INC.
$58
Boston Scientific Corporation
$51
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$50
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
Bayer Healthcare Pharmaceuticals Inc.
$36
Tactile Systems Technology Inc
$20
Lexicon Pharmaceuticals, Inc.
$17
Kestra Medical Technology Services, Inc.
$16
Top 3 companies account for 93.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$55,512
Kiniksa Pharmaceuticals, Ltd.
$20,984
Medtronic Vascular, Inc.
$8,132
Kiniksa Pharmaceuticals International, plc
$6,762
Abbott Laboratories
$4,972
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$4,246
Medtronic, Inc.
$4,001
Edwards Lifesciences Corporation
$3,693
Chiesi USA, Inc.
$3,623
ABIOMED
$1,875
Novartis Pharmaceuticals Corporation
$1,158
Cardiovascular Systems Inc.
$993
Boston Scientific Corporation
$716
CVRx, Inc.
$682
AstraZeneca Pharmaceuticals LP
$608
Inari Medical, Inc.
$393
Bayer HealthCare Pharmaceuticals Inc.
$375
SCPHARMACEUTICALS INC.
$328
Janssen Pharmaceuticals, Inc
$304
BARD PERIPHERAL VASCULAR, INC.
$283
BOSTON SCIENTIFIC CORPORATION
$269
BIOTRONIK INC.
$262
Actelion Pharmaceuticals US, Inc.
$229
AngioDynamics, Inc.
$227
E.R. Squibb & Sons, L.L.C.
$224
Reflow Medical Inc
$214
ShockWave Medical, Inc
$209
Impulse Dynamics (USA) Inc.
$202
PFIZER INC.
$194
Alnylam Pharmaceuticals Inc.
$194
Boehringer Ingelheim Pharmaceuticals, Inc.
$182
KCI USA, Inc
$163
Merck Sharp & Dohme LLC
$124
iRhythm Technologies, Inc.
$121
Amgen Inc.
$109
ASAHI INTECC USA, INC.
$91
Philips Electronics North America Corporation
$91
Getinge USA Sales, LLC
$89
CHIESI USA, INC.
$87
HEARTFLOW, INC.
$80
Cardinal Health 200, LLC
$69
Amryt Pharma Holdings Ltd
$67
Bayer Healthcare Pharmaceuticals Inc.
$61
Amarin Pharma Inc.
$59
CARDIVA MEDICAL, INC.
$57
SANOFI-AVENTIS U.S. LLC
$44
Venclose Inc.
$43
Kestra Medical Technology Services, Inc.
$39
Lexicon Pharmaceuticals, Inc.
$36
Bard Peripheral Vascular, Inc.
$36
CORDIS US CORP.
$31
United Therapeutics Corporation
$29
Tactile Systems Technology Inc
$20
Merck Sharp & Dohme Corporation
$20
Celgene Corporation
$19
Teleflex LLC
$19
Regeneron Healthcare Solutions, Inc.
$16
Esperion Therapeutics, Inc.
$14
Coala Life Inc
$13
Penumbra, Inc.
$10
Top 3 companies account for 68.4% of all-time payments
Associated products mentioned in payments ›
(5028) IGT Devices Systems Undivided · ABSOLUTE PRO · ALPHAVAC · AMPLATZER · AMPLATZER AMULET · AMPLATZER TALISMAN · AMPLATZER TorqVue Delivery Systm · AMPLATZER Vascular Plugs · AMVUTTRA · ANDEXXA · AVVIGO Guidance System · Absolute Pro vascular stent system · Accent Pacemaker · Adempas · Arcalyst · Asahi Fielder coronary guide wire · Assure WCD · Astron; Pulsar; AstronPulsar · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CONFIRM RX · COREVALVE EVOLUT R · Cardiohelp · Cardiva VASCADE 6/7F VCS · Coala Heart Monitor · Concerto · CoreValve Evolut · Coronary Orbital Atherectomy System · DIAMONDBACK PERIPHERAL · Diamondback Peripheral · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EVKEEZA · EVRSF · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EnSite Velocity System Expansion Modules · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · GENERAL - STRUCTURAL HEART · HAWKONE · HawkOne · INFINITI Diagnostic Catheter · Impella · Indigo System · Inpefa · JARDIANCE · JOT DX · Juxtapid · KENGREAL · KENGREAL 50MG/10ML L · Kerendia · LEQVIO · LINQ II · LUTONIX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MAMBA · MANTA Vascular Closure Device · MICRA · MITRACLIP · MULTAQ · MYNX CONTROL · Merlin Connectivity and Remote · Mitra Clip system · MitraClip System · NAVITOR · NEXLETOL · ONPATTRO · ONYX FRONTIER · OPSUMIT · ORENITRAM · OptiCross · Optimizer · Optis Coronary Imaging System · Orsiro · Ozempic · PASCAL · PERCLOSE PROGLIDE · PERIPHERAL VASCULAR · PK Papyrus · PORTICO · Peripheral Orbital Atherectomy System · Pulsar · QT Vascular Chocolate PTA Balloon · QUADRA ASSURA · REVEAL LINQ · RYBELSUS · Repatha · Resolute · Reveal LINQ · Rybelsus · S · SAPIEN 3 Ultra RESILIA · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Supera peripheral stent system · UPTRAVI · Ultimum Standard Introducer · VAC VIA · VERQUVO · VISTA BRITE · VYNDAQEL · Vascepa · Venclose Maven Catheter · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · Xience Sierra Coronary Stent · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (73%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
239
Per 100K population
7.3
County median income
$102,285
Nearest hospital
GROSSMONT HOSPITAL
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Barvalia is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 6% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Barvalia experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Barvalia performed 526 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barvalia receive payments from pharmaceutical companies?
Yes. Dr. Barvalia received a total of $123,702 from 60 companies across 760 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barvalia's costs compare to other cardiologists in El Cajon?
Dr. Barvalia's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barvalia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in El Cajon
Browse cardiologists in El Cajon ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Kiniksa Pharmaceuticals, Ltd. Payments to Doctors
See all physicians who received payments from Kiniksa Pharmaceuticals, Ltd.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology